Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.
- Status
- COMPLETED
- Phase
- PHASE3
Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
- Status
- COMPLETED
- Phase
- NA